Cargando…
Insulin Analogs—Is There a Compelling Case to Use Them? No!
The availability of insulin analogs has offered insulin replacement strategies that are proposed to more closely mimic normal human physiology. Specifically, there are a considerable number of reports demonstrating that prandial insulin analogs (lispro, aspart, glulisine) have pharmacokinetic and ph...
Autor principal: | Davidson, Mayer B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030087/ https://www.ncbi.nlm.nih.gov/pubmed/24855160 http://dx.doi.org/10.2337/dc13-2915 |
Ejemplares similares
-
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010) -
Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013) -
“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
por: Holloszy, John O.
Publicado: (2013) -
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment
por: Umpierrez, Guillermo E., et al.
Publicado: (2013) -
A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013)